Literature DB >> 23168282

Real incidence of diabetes mellitus in a coronary disease population.

Jesús M de la Hera1, Jose M García-Ruiz, Pablo Martínez-Camblor, María Martín, Ana L Tellería, Cecilia Corros, Francisco Torres, Oliva C Fernández-Cimadevilla, Irene Alvarez-Pichel, Esmeralda Capín, Pablo Avanzas, Elías Delgado.   

Abstract

The high prevalence of unknown diabetes mellitus (DM) in patients with coronary disease and that the oral glucose tolerance test (OGTT) is the best diagnostic method in this context are well known. However, data about the incidence of DM in this population have not been well described. In the present study, we sought to determine the actual incidence of new-onset DM in patients with coronary disease using the OGTT. Our secondary objective was to validate a predictive model. We studied a series of 338 patients with coronary disease without known DM using the OGTT. After the OGTT, the patients were reclassified as normoglycemic, prediabetic, and unknown DM, according to the American Diabetes Association 2010 criteria. After 3 years of follow-up, the patients without DM were again reassessed using the OGTT. We then built a predictive model using the multivariate logistic regression method and validated it using the leave-one-out method. The final sample was 191 patients. The mean follow-up was 3.13 years. The overall incidence of DM was 43.6 cases/1,000 person-years (95% confidence interval [CI] 26.8 to 60.4). The incidence was significantly different between the initially normoglycemic patients (11.5%, 95% CI 2.3% to 31.8%) and the prediabetic patients (70.5%, 95% CI 42.7% to 98.3%; p <0.001). A risk model that included the glucose level 2 hours after challenge, glycosylated hemoglobin and triglyceride levels, and presence of noncoronary vascular disease showed good predictive capacity for incident DM (area under the curve 0.882, 95% CI 0.819 to 0.946; p <0.0001). In conclusion, the real incidence of new DM is very high in the coronary population, especially in those with prediabetes. It is necessary to use the OGTT for diagnosis, but we can optimize its indication using a risk model.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23168282     DOI: 10.1016/j.amjcard.2012.10.008

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Clinicopathologic characteristics, prevalence, and risk factors of spontaneous diabetes in sooty mangabeys (Cercocebus atys).

Authors:  Amelia C Jones; James G Herndon; Cynthia L Courtney; Lynn Collura; Joyce K Cohen
Journal:  Comp Med       Date:  2014-06       Impact factor: 0.982

2.  Impact of post-challenge hyperglycemia on clinical outcomes in Japanese patients with stable angina undergoing percutaneous coronary intervention.

Authors:  Shoichi Kuramitsu; Hiroyoshi Yokoi; Takenori Domei; Akihiro Nomura; Hirotoshi Watanabe; Kyohei Yamaji; Yoshimitsu Soga; Takeshi Arita; Katsuhiro Kondo; Shinichi Shirai; Kenji Ando; Koyu Sakai; Masashi Iwabuchi; Hedeyuki Nosaka; Masakiyo Nobuyoshi
Journal:  Cardiovasc Diabetol       Date:  2013-05-07       Impact factor: 9.951

3.  Long-term clinical outcome in patients with acute coronary syndrome and dysglycaemia.

Authors:  Jeanette Kuhl; Gun Jörneskog; Malin Wemminger; Mattias Bengtsson; Pia Lundman; Majid Kalani
Journal:  Cardiovasc Diabetol       Date:  2015-09-17       Impact factor: 9.951

4.  Antihypertensive Drug Use and New-Onset Diabetes in Female Patients with Coronary Artery Disease: A Population-based Longitudinal Cohort Study.

Authors:  Yi-Sheng Liou; Hung-Yi Chen; Lyun Tien; Yi-Sian Gu; Gwo-Ping Jong
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.